Business Wire (Wed, 7:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Thu, 4:00PM)
-
Business Wire (Thu, 7:00AM)
-
-
Business Wire (May 1, 2013)
-
-
-
-
Business Wire (Apr 17, 2013)
-
-
-
-
-
-
Business Wire (Feb 19, 2013)
-
Lundbeck Could Cheer Up Patient InvestorsStephen Simpson • Wed, Feb 13
-
Business Wire (Feb 5, 2013)
-
-
-
-
-
Alkermes Narrows Loss on Higher RevenueZacks Investment Research • Thu, Aug 4, 2011 -
Alkermes Earnings PreviewZacks Investment Research • Mon, Jan 31, 2011
-
-
Alkermes Outlook Remains BleakZacks Investment Research • Tue, May 26, 2009
-
Is A New Blockbuster Drug In The Works For Alkermes?Steven T. Gold • Mon, Jun 4, 2007
-
-
-
-
-
-
-
-
Lundbeck Could Cheer Up Patient InvestorsStephen Simpson • Wed, Feb 13
-
-
-
-
3 Highly Liquid Mid Caps With Strong Growth ProjectionsZetaKap • Thu, Sep 6, 2012 -
8 Highly Liquid Healthcare Stocks Undervalued By EPS TrendsKapitall • Thu, Aug 23, 2012 -
-
-
-
-
-
-
-
Alkermes' CEO Discusses F2Q13 Results - Earnings Call TranscriptThu, Nov 1, 2012
-
Alkermes' CEO Discusses F1Q13 Results - Earnings Call TranscriptThu, Jul 26, 2012
-
Alkermes CEO Discusses F2Q2011 Results - Earnings Call TranscriptSun, Nov 7, 2010
-
Alkermes Q1 2011 Earnings Conference Call TranscriptFri, Aug 6, 2010
-
Alkermes Inc. F4Q10 (Qtr End 03/31/10) Earnings Call TranscriptThu, May 13, 2010
-
Alkermes, Inc. F3Q10 (Qtr End 12/31/09) Earnings Call TranscriptThu, Feb 4, 2010
-
Alkermes, Inc. Q3 2009 Earnings Call TranscriptTue, Feb 17, 2009
-
Alkermes, Inc. F2Q09 (Qtr End 09/30/08) Earnings Call TranscriptTue, Nov 18, 2008
-
Alkermes, Inc F1Q09 (Qtr End 06/30/08) Earnings Call TranscriptThu, Aug 7, 2008
-
Alkermes Inc. F408 (Qtr End 03/31/2008) Earnings Call TranscriptThu, May 22, 2008
-
Alkermes Inc., F3Q08 (Qtr End 12/31/07) Earnings Call TranscriptSun, Feb 10, 2008
-
Business Wire (Wed, 7:00AM)
-
Business Wire (Thu, 4:00PM)
-
Business Wire (Thu, 7:00AM)
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 17, 2013)
-
at CNBC.com (Feb 27, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Jan 31, 2013)
-
Business Wire (Jan 24, 2013)
-
Business Wire (Jan 2, 2013)
-
Business Wire (Nov 7, 2012)
-
Business Wire (Nov 1, 2012)
-
Business Wire (Oct 25, 2012)
-
Business Wire (Sep 25, 2012)
-
Business Wire (Sep 19, 2012)
-
Business Wire (Aug 30, 2012)
ALKS vs. ETF Alternatives
Company Description
Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients’ lives. We developed, manufacture and commercialize VIVITROL® for alcohol dependence and manufacture RISPERDAL® CONSTA® for schizophrenia and bipolar disorder. Our... More
